Results 21 to 30 of about 2,326 (226)
Insight on ecDNA-mediated tumorigenesis and drug resistance [PDF]
Extrachromosomal DNAs (ecDNAs) are a pervasive feature found in cancer and contain oncogenes and their corresponding regulatory elements. Their unique structural properties allow a rapid amplification of oncogenes and alter chromatin accessibility ...
Qing Huang +3 more
doaj +4 more sources
Imaging extrachromosomal DNA (ecDNA) in cancer [PDF]
Extrachromosomal DNA (ecDNA) are circular regions of DNA that are found in many cancers. They are an important means of oncogene amplification, and correlate with treatment resistance and poor prognosis. Consequently, there is great interest in exploring
Karin Purshouse +2 more
semanticscholar +8 more sources
Extrachromosomal DNA is a common cause of oncogene amplification in cancer. The non-chromosomal inheritance of ecDNA enables tumors to rapidly evolve, contributing to treatment resistance and poor outcome for patients.
Miin S Lin +6 more
doaj +3 more sources
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. [PDF]
Intratumour heterogeneity and phenotypic plasticity drive tumour progression and therapy resistance1,2. Oncogene dosage variation contributes to cell-state transitions and phenotypic heterogeneity3, thereby providing a substrate for somatic evolution ...
Fiorini E +31 more
europepmc +5 more sources
Oncogene Silencing via ecDNA Micronucleation [PDF]
Extrachromosomal DNA (ecDNA) is a common source of oncogene amplification across many types of cancer. The non-Mendelian inheritance of ecDNA contributes to heterogeneous tumour genomes that rapidly evolve to resist treatment. Here, using single-cell and
Brückner L +48 more
europepmc +4 more sources
ecPath detects ecDNA in tumors from histopathology images [PDF]
Circular extrachromosomal DNA (ecDNA) can drive tumor initiation, progression and resistance in some of the most aggressive cancers and is emerging as a promising anti-cancer target.
Mudra Choudhury +21 more
semanticscholar +3 more sources
Oncogene expression from extrachromosomal DNA is driven by copy number amplification and does not require spatial clustering in glioblastoma stem cells [PDF]
Extrachromosomal DNA (ecDNA) are frequently observed in human cancers and are responsible for high levels of oncogene expression. In glioblastoma (GBM), ecDNA copy number correlates with poor prognosis.
Karin Purshouse +10 more
doaj +4 more sources
EcDNA-borne PVT1 fusion stabilizes oncogenic mRNAs
SummaryExtrachromosomal DNA (ecDNA) amplifications are prevalent drivers of human cancers. We show that ecDNAs exhibit elevated structural variants leading to gene fusions that produce oncogene fusion transcripts. The long noncoding RNA (lncRNA) genePVT1is the most recurrent structural variant across cancer genomes, withPVT1-MYCfusions arising most ...
Hyerim Yi +24 more
semanticscholar +5 more sources
ATACAmp: a tool for detecting ecDNA/HSRs from bulk and single-cell ATAC-seq data [PDF]
Background High oncogene expression in cancer cells is a major cause of rapid tumor progression and drug resistance. Recent cancer genome research has shown that oncogenes as well as regulatory elements can be amplified in the form of extrachromosomal ...
Hansen Cheng +10 more
doaj +2 more sources
Histone 3 lysine 56 acetylation (H3K56ac) regulates extrachromosomal DNA (ecDNA) hub maintenance [PDF]
Extrachromosomal DNAs (ecDNAs) play an important role in tumor progression. ecDNA hubs have been shown to be anchored by BRD4, a chromatin reader. However, the chromatin organization of ecDNA hub remains unknown.
Li-Zhu Liao +6 more
doaj +2 more sources

